Pub. Date : 2012 Nov
PMID : 23090888
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Although both are potent and specific BCR-ABL TKIs, dasatinib and nilotinib exhibit unique pharmacological profiles and response patterns relative to different patient characteristics, such as disease stage and BCR-ABL mutational status. | Dasatinib | ABL proto-oncogene 1, non-receptor tyrosine kinase | Homo sapiens |